💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alnylam Pharmaceuticals, Inc. (ALNY)
« Back to company indexALNY Chatter Timeline
Stock Ticker for ALNY
Most Active Tweeters for ALNY
| User | Tweets |
|---|---|
| @A1Syad | 6 |
| @newsfilterio | 6 |
| @SweepCastApp | 5 |
| @Jarvis_Alerts | 4 |
| @MarcJacksonLA | 4 |
Recent Tweets for ALNY
 |
@Jarvis_Alerts $ALNY 230C Exp:18-Mar-22 ?? ? Total(Day): $182,400 #UnusualActivity Sign-up free for beta ver.:… https://t.co/wDksA8WPHj December 3rd 2021, 10:12pm |
 |
@newsfilterio Alnylam Ranks #1 in Boston Globe's Top Places to Work List for 2021 $ALNY https://t.co/pcdqdJ9iXH December 3rd 2021, 2:12am |
 |
@A1Syad $ALNY Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/8eWq53P64o December 3rd 2021, 2:12am |
 |
@BioCentury RT @FishburnSimone: I talked to @JMaraganore as he departs $ALNY, about innovation, access and more. "We’ll find through Build Back Better… December 2nd 2021, 7:12pm |
 |
@equity_newswire $ALNY Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021 https://t.co/nfkBWFFWIE December 2nd 2021, 5:12pm |
 |
@BestThetaTrades ?Expensive Options Alert? $ALNY 30 DTE option chain priced at 62.25% IV PA Forecast indicates it should be 50.11%… https://t.co/1IZkwSbSDw December 2nd 2021, 4:12pm |
 |
@gcassidy718 $ALNY Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021 https://t.co/TAHPtWQlj3 December 2nd 2021, 2:12pm |
 |
@otcdynamics $ALNY Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021 https://t.co/gOTuGJl6wr December 2nd 2021, 1:12pm |
 |
@StckPro $ALNY NEW ARTICLE : Alnylam Ranks #1 in Boston Globe's Top Places to Work List for 2021 https://t.co/HtVHYXRhmW Get… https://t.co/k9kuGjSCSP December 2nd 2021, 1:12pm |
 |
@StockNewsBot2 $ALNY Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021 https://t.co/bAtIg508o7 December 2nd 2021, 1:12pm |
 |
@quantisnow $ALNY ? Alnylam Ranks #1 in Boston Globe's Top Places to Work List for 2021 https://t.co/0RMI9vIMCW 45 seconds delayed. December 2nd 2021, 1:12pm |
 |
@stock_titan $ALNY Alnylam Ranks #1 in Boston Globe’s Top Places to Work List for 2021 https://t.co/XyOCaFrAyO December 2nd 2021, 1:12pm |
 |
@bthefirsttoknow First out// $ALNY: Alnylam Ranks #1 in Boston Globe's Top Places to Work List for 2021 https://t.co/2qbcL9FDFU December 2nd 2021, 1:12pm |
 |
@BioPharmaJosh RT @jeff_cranmer: As @JMaraganore readies to leave $ALNY, the pioneering biotech exec's legacy will be as much about pushing the envelope o… December 2nd 2021, 12:12pm |
 |
@FishburnSimone I talked to @JMaraganore as he departs $ALNY, about innovation, access and more. "We’ll find through Build Back Bet… https://t.co/20dAcYJIi9 December 2nd 2021, 12:12pm |
 |
@jeff_cranmer As @JMaraganore readies to leave $ALNY, the pioneering biotech exec's legacy will be as much about pushing the enve… https://t.co/V0SmOYLKqV December 2nd 2021, 6:12am |
 |
@CKlasmeier RT @BioCentury: BioCentury's latest round up of management moves: $ALNY's Maraganore headlines Arch’s latest crop of venture partners, Five… December 2nd 2021, 3:12am |
|
@BioCentury BioCentury's latest round up of management moves: $ALNY's Maraganore headlines Arch’s latest crop of venture partne… https://t.co/ZP3XlZ7j8P December 2nd 2021, 3:12am |
 |
@Gambiste1 RT @MaisaCorp: $ABUS currently receives royalties from Alnylam $ALNY on sales of Onpattro at a rate of up to 2.33% of global net sales. I… December 1st 2021, 11:12pm |
 |
@MaisaCorp $ABUS currently receives royalties from Alnylam $ALNY on sales of Onpattro at a rate of up to 2.33% of global net… https://t.co/duXTLuscgU December 1st 2021, 10:12pm |
|
@A1Syad $ALNY Awaiting Short Signal Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/iIanWsEpXv December 1st 2021, 8:12pm |
|
@BestThetaTrades ?Expensive Options Alert? $ALNY 30 DTE option chain priced at 59.91% IV PA Forecast indicates it should be 49.66%… https://t.co/ltsKrnrny6 December 1st 2021, 4:12pm |
 |
@MarcJacksonLA $ALNY Leerink Maintains Alnylam Pharmaceuticals Hold Rating https://t.co/xKruSlBFiq December 1st 2021, 3:12pm |
|
@StckPro $ALNY NEW ARTICLE : Alnylam Pharma (ALNY) Receives a Hold from Leerink Partners https://t.co/vwUhELPk3c Get all the… https://t.co/FIBRy1f1JF December 1st 2021, 9:12am |
|
@A1Syad $ALNY Looks oversold Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/1Hm4edEeAk November 29th 2021, 10:11pm |
 |
@NicJanvier RT @MarcJacksonLA: $ALNY Alnylam’s new CEO hopes appointment inspires underrepresented groups https://t.co/6AFgiJU8cA via @statnews November 29th 2021, 8:11pm |
|
@MarcJacksonLA $ALNY Alnylam’s new CEO hopes appointment inspires underrepresented groups https://t.co/6AFgiJU8cA via @statnews November 29th 2021, 8:11pm |
 |
@ChartMill $ALNY was analyzed by 28 analysts. The buy consensus is at 75%. So analysts seem to be mildly confident about $ ...… https://t.co/QVJOfPdwJK November 29th 2021, 5:11pm |
 |
@govermentchild $alny presenting at 2 different healthcare conferences Tuesday and Thursday . Look for move upwards . November 29th 2021, 3:11pm |
 |
@MarketChmln $ALNY upcoming event November 30: Evercore ISI 4th Annual HealthCONx Conference. Options expiring on December 17 th… https://t.co/wgpKZGCJEr November 28th 2021, 11:11pm |
 |
@Tickeron $ALNY in Uptrend: price expected to rise as it breaks its lower Bollinger Band on October 27, 2021. View odds for t… https://t.co/TVMskidN8l November 28th 2021, 11:11pm |
 |
@SweepCastApp SweepCast alerted: $ALNY with Unusual Options Activity Alerted on $200 PUT Expiring: 03-18-2022 worth 32K? |? See more in profile November 28th 2021, 9:11pm |
|
@SweepCastApp SweepCast alerted: $ALNY with Unusual Options Activity Alerted on $200 PUT Expiring: 03-18-2022 worth 32K? |? Check… https://t.co/NNipx3CbG4 November 27th 2021, 10:11am |
|
@A1Syad $ALNY So easy to trade with the Short / Buy signals. Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/PyvhiLn8uA November 26th 2021, 9:11pm |
 |
@tick_signals $ALNY Signal Update As of today, ALNY is up +3.28% from buy price 186.29 in 3days and on track to achieve tar… https://t.co/rZbumebm8C November 26th 2021, 4:11pm |
 |
@SoupisF RT @InsideArbitrage: Alnylam Pharmaceuticals $ALNY could be a potential takeover target for Novartis AG $NVS https://t.co/U758WG9HoK November 25th 2021, 7:11pm |
 |
@BiochemKev $ALNY 1st to Market RNAi in 2018 Nov19 2021 R&D Day "RNAi targets mRNA of disease causing proteins for destructio… https://t.co/2gSEJcuPxF November 25th 2021, 5:11pm |
|
@SweepCastApp SweepCast alerted: $ALNY with Unusual Options Activity Alerted on $185 CALL Expiring: 12-17-2021 worth 55K? |? Chec… https://t.co/kFPRPUbYhk November 25th 2021, 9:11am |
 |
@sorkaridorkar RT @fwpharma: Sanofi, Alnylam's fitusiran hits bleeding endpoints in haemophilia studies $SNY $ALNY https://t.co/7KiDE1zdnD November 25th 2021, 2:11am |
|
@A1Syad $ALNY Looks overbought Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/hmfF656ap0 November 25th 2021, 12:11am |
 |
@fwpharma Sanofi, Alnylam's fitusiran hits bleeding endpoints in haemophilia studies $SNY $ALNY https://t.co/7KiDE1zdnD November 24th 2021, 10:11pm |
|
@govermentchild $alny lots of reason to hold on to this name . Takeover candidate I’m Hoping . GS updated it to a buy recently. Goo… https://t.co/LFcx25I4K9 November 24th 2021, 3:11am |
 |
@Steve_382 $ALNY Even I could follow this article, so it must be pretty basic. Sounds great though. https://t.co/MXLdteySxQ November 24th 2021, 1:11am |
|
@newsfilterio Alnylam to Webcast Presentations at Upcoming Investor Conferences $ALNY https://t.co/XEwJ78Rmf7 November 23rd 2021, 7:11pm |
|
@A1Syad $ALNY Awaiting Short Signal Register for 7-Day Trial Access at https://t.co/4iPw4wGRcw https://t.co/hhUrjlWLKF November 23rd 2021, 7:11pm |
|
@equity_newswire $ALNY Alnylam to Webcast Presentations at Upcoming Investor Conferences https://t.co/nAKjTZXC9p November 23rd 2021, 6:11pm |
|
@gcassidy718 $ALNY Alnylam to Webcast Presentations at Upcoming Investor Conferences https://t.co/s2PGo7l8QQ November 23rd 2021, 4:11pm |
 |
@FlashAlert_me $ALNY [15s. delayed]: Issued Press Release on November 23, 08:00:00: Alnylam to Webcast Presentations at Upcoming I… https://t.co/HJNGlz6rby November 23rd 2021, 1:11pm |
|
@StockNewsBot2 $ALNY Alnylam to Webcast Presentations at Upcoming Investor Conferences https://t.co/fCzguCAZqf November 23rd 2021, 1:11pm |
|
@stock_titan $ALNY Alnylam to Webcast Presentations at Upcoming Investor Conferences https://t.co/ZgDBSkrHKi November 23rd 2021, 1:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?